Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis

Blood

Volumn 116, Issue 15, 2010, Pages 2768-2775

  Yokoyama, Takashi ^a   Kanno, Yohei ^a   Yamazaki, Yukari ^a   Takahara, Tomoko ^a   Miyata, Satoshi ^b   Nakamura, Takuro ^a  

^a CANCER INSTITUTE   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN TRIB1; TUMOR PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MAP2K1 PROTEIN, HUMAN; MYELOID ECOTROPIC VIRAL INTEGRATION SITE 1 PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR HOXA9; TRIB1 PROTEIN, HUMAN;

ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL RENEWAL; ENZYME BINDING; ENZYME DEGRADATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CHEMISTRY; DOWN REGULATION; FEMALE; GENETICS; HELA CELL LINE; LEUKEMIA, MYELOID; METABOLISM; MOUSE; ONCOGENE; PATHOLOGY; PHOSPHORYLATION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BONE MARROW CELLS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; ONCOGENES; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN-SERINE-THREONINE KINASES;

EID: 77957963658     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-246264     Document Type: Article

References (34)

1. Van Etten RA. Aberrant cytokine signaling in leukemia. Oncogene. 2007;26(47):6738-6749.
2. Braun BS, Shannon K. Targeting Ras in myeloid leukemias. Clin Cancer Res. 2008;14(8):2249-2252.
3. Wang L, Wang J, Blaser BW, et al. Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia. Blood. 2007;110(6): 2075-2083. (Pubitemid 47443925)
4. Grosshans J, Wieschaus E. A genetic link between morphogenesis and cell division during formation of the ventral furrow in drosophila. Cell. 2000;101(5):523-531.
5. Mata J, Curado S, Ephrussi A, Rorth P. Tribbles coordinates mitosis and morphogenesis in drosophila by regulating String/CDC25 proteolysis. Cell. 2000;101(5):511-522.
6. Kiss-Toth E, Bagstaff SM, Sung HY, et al. Human Tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem. 2004;279(41):42703-42708.
7. Sung HY, Guan H, Czibula A, et al. Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. J Biol Chem. 2007;282(25):18379-18387.
8. Rorth P, Szabo K, Texido G. The level of C/EBP protein is critical for cell migration during drosophila oogenesis and is tightly controlled by regulated degradation. Mol Cell. 2000;6(1):23-30.
9. Jin G, Yamazaki Y, Takuwa M, et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood. 2007;109(9):3998-4005.
10. Keeshan K, He Y, Wouters BJ, et al. Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia. Cancer Cell. 2006;10(5): 401-411.
11. Iwasaki M, Kuwata T, Yamazaki Y, et al. Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood. 2005;105(2):784-793. (Pubitemid 40070766)
12. Nakamura T, Yamazaki Y, Saiki Y, et al. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell protooncogene product. Mol Cell Biol. 2000;20(9): 3178-3186.
13. Kogan SC, Ward JM, Anver MR, et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002;100(1): 238-245.
14. Cha H, Lee EK, Shapiro P. Identification of a C-terminal region that regulates mitogen-activated protein kinase kinase-1 cytoplasmic localization and ERK activation. J Biol Chem. 2001;276(51):48494-48501. (Pubitemid 33647213)
15. Kiss-Toth E, Wyllie DH, Holland K, et al. Functional mapping and identification of novel regulators for the Toll/Interleukin-1 signaling network by transcription expression cloning. Cell Signal. 2006;18(2):202-214.
16. Hegedus Z, Czibula A, Kiss-Toth E. Tribbles: a family of kinase-like proteins with potent signaling regulatory function. Cell Signal. 2007;19(2):238-250.
17. Seher TC, Leptin M. Tribbles, a cell-cycle brake that coordinates proliferation and morphogenesis during Drosophila gastrulation. Curr Biol. 2000; 10(11):623-629.
18. Ohoka N, Yoshii S, Hattori T, et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 2005;24(6):1243-1255. (Pubitemid 40516607)
19. Naiki T, Saijou E, Miyaoka Y, et al. TRB2, a mouse tribbles ortholog, suppresses adipocyte differentiation by inhibiting AKT and C/EBPβ. J Biol Chem. 2007;282(33):24075-24082.
20. Qi L, Heredia JE, Altarejos JY, et al. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science. 2006;312(5781):1763-1766.
21. Ross SE, Radomska HS, Wu B, et al. Phosphorylation of C/EBPα inhibits granulopoiesis. Mol Cell Biol. 2004;24(2):675-686.
22. Storlazzi CT, Fioretos T, Surace C, et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet. 2006;15(6):933-942.
23. Rothlisberger B, Heizmann M, Bargetzi MJ, Huber AR. TRIB1 overexpression in acute myeloid leukemia. Cancer Genet Cytogenet. 2007; 176(1):58-60.
24. Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 2005;106(1):254-264.
25. Yamamoto M, Uematsu S, Okamoto T, et al. Enhanced TLR-mediated NF-IL6-dependent gene expression by Trib1 deficiency. J Exp Med. 2007; 204(9):2233-2239.
26. Nerlov C. C/EBPα mutations in acute myeloid leukaemias. Nat Rev Cancer. 2004;4(5):394-400.
27. Pabst T, Mueller BU. Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin Cancer Res. 2009;15(17):5303-5307.
28. Radomska HS, Basseres DS, Zheng R, et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med. 2006;203(2):371-381.
29. Gilby DC, Sung HY, Winship PR, et al. Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia. Immunol Lett. 2010;130(1-2):115-124.
30. Zindy F, Eischen CM, Randle DH, et al. Myc signaling via the ARF tumor suppressor regulated p53-dependent apoptosis and immortalization. Genes Dev. 1998;12(15):2424-2433.
31. Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M. Deregulated beta-catenin induces a p53-and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 2001; 20(17):4912-4922.
32. Wermuth PJ, Buchberg AM. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood. 2005;105(3):1222-1230.
33. Valk PJM, Verhaak RGW, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004; 350(16):1617-1628.
34. Gilliland DG. Molecular genetics of human leukemias: new insights into therapy. Semin Hematol. 2002;39(4 suppl 3):6-11.